Neogenomics (NEO) Intangibles (2012 - 2026)

Neogenomics has reported Intangibles for 15 years, with the latest figure at $278.9 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles fell 15.82% year-over-year to $278.9 million; the trailing twelve-month figure through Mar 2026 stood at $278.9 million (down 15.82% YoY), and the FY2025 full-year result was $286.5 million, down 15.65% from the prior year.
• Intangibles for Q1 2026 stood at $278.9 million, down from $286.5 million in the prior quarter.
• The five-year high for Intangibles was $433.8 million in Q1 2022, with the low at $278.9 million in Q1 2026.
• Historically, Intangibles has averaged $360.7 million across 5 years, with a median of $364.8 million in 2024.
• Annual changes were most pronounced in 2022 — Intangibles surged 267.05% — and 2026, when it fell 15.82%.
• Neogenomics' Intangibles stood at $408.3 million in 2022, then retreated by 8.61% to $373.1 million in 2023, then retreated by 8.96% to $339.7 million in 2024, then retreated by 15.65% to $286.5 million in 2025, then decreased by 2.66% to $278.9 million in 2026.
• The last three Intangibles figures came in at $278.9 million (Q1 2026), $286.5 million (Q4 2025), and $294.2 million (Q3 2025), per Business Quant data.